PRESS RELEASE published on 09/25/2024 at 22:01, 1 year 8 months ago Abivax fait le point sur la stratégie du programme de traitement combiné dans la RCH et annonce les données précliniques précoces de combinaison d’obefazimod et d’étrasimod dans un modèle murin MICI Abivax annonce des données précliniques de combinaison d'obefazimod et d'étrasimod dans un modèle murin MICI pour traiter la RCH. Prochaine publication au T4 2024 Abivax Obefazimod Etrasimod Traitement Combiné RCH
BRIEF published on 09/19/2024 at 18:05, 1 year 9 months ago ABIVAX : Nombre d’actions et droits de vote au 31 août 2024 Euronext Paris Droits De Vote Capital Social Biotechnologie Abivax
BRIEF published on 09/19/2024 at 18:05, 1 year 9 months ago ABIVAX: Number of shares and voting rights as of August 31, 2024 Euronext Paris Share Capital Voting Rights Biotechnology Abivax
PRESS RELEASE published on 09/19/2024 at 18:00, 1 year 9 months ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.24. ABIVAX communique sur le nombre d'actions et de droits de vote au 31.08.24, conformément aux dispositions réglementaires. Société biotechnologique spécialisée en traitements thérapeutiques innovants Droits De Vote Capital Social Biotechnologie Abivax Traitements Thérapeutiques
BRIEF published on 09/09/2024 at 23:01, 1 year 9 months ago Déclaration de Marc de Garidel sur le Rapport Financier Semestriel 2024 d'Abivax Abivax Transparence IFRS Rapport Financier Patrimoine
BRIEF published on 09/09/2024 at 23:01, 1 year 9 months ago Statement by Marc de Garidel on Abivax's 2024 Half-Year Financial Report Financial Report Abivax Transparency IFRS Heritage
PRESS RELEASE published on 09/09/2024 at 22:56, 1 year 9 months ago Attestation du responsable du Rapport financier semestriel 2024 Déclaration de la personne responsable du rapport financier intermédiaire pour le semestre écoulé conforme aux normes IFRS, présentant une image fidèle de la société Déclaration Rapport Financier Normes IFRS Semestre Personne Responsable
PRESS RELEASE published on 09/09/2024 at 22:53, 1 year 9 months ago Rapport des CAC sur l'information financière semestrielle 2024
PRESS RELEASE published on 09/09/2024 at 22:43, 1 year 9 months ago Rapport CAC sur l'information financière semestrielle 2024
BRIEF published on 09/09/2024 at 22:40, 1 year 9 months ago ABIVAX présente ses résultats semestriels 2024 Résultats Semestriels Abivax Cybersécurité Contrôle Interne Défaillances
Published on 06/22/2026 at 19:45, 49 minutes ago Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly
Published on 06/22/2026 at 15:58, 4 hours 36 minutes ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 5 hours 4 minutes ago NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 5 hours 34 minutes ago Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 14:01, 6 hours 33 minutes ago Worksport (NASDAQ:WKSP) Achieves 35% May Gross Margin, Lands Meyer Distribution, Targets $36M+ Revenue Run-Rate
Published on 06/22/2026 at 19:27, 1 hour 7 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 06/22/2026 at 18:54, 1 hour 39 minutes ago EQS-Adhoc: Brenntag SE publishes preliminary operating EBITDA for the second quarter of 2026 and increases its guidance for the financial year 2026
Published on 06/22/2026 at 18:30, 2 hours 4 minutes ago Avolta awarded 10-year contract at Orlando International Airport across travel retail and F&B
Published on 06/22/2026 at 18:05, 2 hours 29 minutes ago Bybit EU Strengthens European Positioning Ahead of MiCAR Transition
Published on 06/22/2026 at 18:00, 2 hours 34 minutes ago GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION